Routine aspirin or nonsteroidal anti-inflammatory drugs for the primary prevention of colorectal cancer.

Am Fam Physician

U.S. Preventive Services Task Force Program, Center for Primary Care, Prevention and Clinical Partnerships, Agency for Healthcare Research and Quality, USA.

Published: February 2009

Download full-text PDF

Source

Publication Analysis

Top Keywords

routine aspirin
4
aspirin nonsteroidal
4
nonsteroidal anti-inflammatory
4
anti-inflammatory drugs
4
drugs primary
4
primary prevention
4
prevention colorectal
4
colorectal cancer
4
routine
1
nonsteroidal
1

Similar Publications

Platelets to prevent progression of trauma-induced head bleed in patients on antiplatelet medication.

Surg Pract Sci

June 2023

Mount Carmel Health System, 6001 East Broad Street, Columbus, OH 43213, United States.

Background: There are no established guidelines for transfusing platelets in the setting of traumatic brain injury (TBI)-related intracranial hemorrhage for patients on pre-injury antiplatelet medications (APT). Existing literature has produced mixed results regarding the effectiveness of platelet transfusion in containing bleed size or avoiding craniotomy. We compared outcomes of patients on APT with an intracranial bleed due to trauma, between those who did and who did not receive routine platelet transfusion.

View Article and Find Full Text PDF

Lynch syndrome is associated with an increased risk of cancer, including endometrial cancer. We audited the introduction of a nurse-led testing and management pathway for Lynch syndrome. All 191 patients diagnosed with endometrial cancer at Somerset NHS Foundation Trust between January 2022 and December 2023 were tested for mis-match repair (MMR) protein immunohistochemistry; germline testing was offered to all 13 who were eligible.

View Article and Find Full Text PDF

Background: Radical cystectomy constitutes the standard therapeutic approach for high-risk urothelial carcinomas of the bladder. Contemporary guidelines advise urologists to discontinue anticoagulation therapy during the perioperative period to mitigate the risk of significant intraoperative or postoperative hemorrhage. Nevertheless, in elderly patients with a history of coronary artery disease, the cessation of anticoagulant medication elevates the risk of acute myocardial infarction, thereby posing a substantial threat to their survival.

View Article and Find Full Text PDF

Risk factors for emergency department visits and readmissions for postpartum hypertension.

J Matern Fetal Neonatal Med

December 2025

Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of California (UCLA), Los Angeles, CA, USA.

Objective: Postpartum hypertension accounts for 15 to 20% of postpartum Emergency Department (ED) visits and readmissions in the United States. Postpartum readmission is a quality metric and target of quality improvement as it indicates poor control of hypertension and can portend increased morbidity. We aim to evaluate risk factors for postpartum ED visits and readmissions for hypertension.

View Article and Find Full Text PDF

Lynch Syndrome: Similarities and Differences of Recommendations in Published Guidelines.

J Gastroenterol Hepatol

January 2025

Department of Gastroenterology and Hepatology, Hadassah Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.

Background: In this review, we aimed to compare the recommendations for Lynch syndrome (LS).

Methods: We compared the LS's guidelines of different medical societies, including recommendations for cancer surveillance, aspirin treatment, and universal screening.

Results: Most guidelines for LS patients recommend intervals of 1-2 years for performing colonoscopy, though there is disagreement regarding the age to begin CRC screening (dependent on status as a MLH1/MSH2 or MSH6/PMS2 carrier).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!